Provider review
Remote Pharmacy review
Sells the GLP-1 as a daily tablet under the tongue, not a weekly injection.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$167/mo sema · $229.99/mo tirz, sublingual tablets
Visit Remote PharmacyBoth molecules are compounded sublingual tablets taken once a day. That removes the needle, and with it the thing a low-dose patient usually relies on — the ability to draw a fraction of a syringe.
Price as published
Remote Pharmacy
$167/mo sema · $229.99/mo tirz, sublingual tablets
- Vs median
- $8/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is an oral-first seller, and the route is the whole story. Semaglutide and tirzepatide both arrive as compounded tablets dissolved under the tongue once a day rather than injected once a week, which is genuinely what a lot of readers say they want. Weigh what it costs you, though, and it is not only the price. A tablet is a fixed unit: you take what was made or you do not, so taking a fraction stops being a decision you make with a syringe and becomes a product the seller has to offer. Neither published figure is attached to a dose, both are quoted as floors, and there is no ladder to show what a larger one costs. The homepage also carries a weight-loss figure with no study, cohort or comparison behind it, which is worth reading as marketing rather than evidence.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You do not want to inject, and a daily tablet is worth more to you than a weekly one.
- You want both molecules available in the same format from one provider.
- You want the price visible before an intake rather than after.
Look elsewhere if
- You want to take a fraction of a dose. A tablet cannot be split the way a syringe can.
- You want a dose behind the price. Neither figure has one, and both are floors.
- You weigh outcome claims. The weight-loss figure on the homepage has no study behind it.
What it actually costs
Price as published
$167/mo sema · $229.99/mo tirz, sublingual tablets
- Vs median
- $8/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. There is no low-dose product, and the route removes the usual workaround: a daily sublingual tablet cannot be split the way a syringe can, so taking a fraction depends entirely on the seller offering a smaller tablet. Neither published figure is attached to a dose, so a microdoser cannot price their own regime even in principle.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Sublingual tablets rather than injections, which removes the needle for readers who want that.
- Both prices are published before any intake, for both molecules.
- Prices sit meaningfully below the brand-name cash route for the same active ingredients.
Pharmacy, labs and oversight
Remote Pharmacy does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Remote Pharmacy publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Remote Pharmacy is an oral-first seller: its semaglutide and tirzepatide are compounded sublingual tablets taken once a day, not weekly injections, and that changes the calculation for anyone reading this page. A daily tablet removes the needle, which is the reason most people ask about orals in the first place. It also removes the thing a microdoser relies on — the ability to draw a fraction of a syringe. You take the tablet the manufacturer made or you do not, so a low dose has to be a product the seller offers rather than a decision you make at the point of injection. Neither price is tied to a dose, both are "as low as", and the weight-loss figure on the homepage is offered without a study, a cohort or a timeframe beyond the headline.
The honest cons
A daily tablet cannot be split the way a syringe can, so a low dose depends on the seller offering one.
- Both figures are "as low as" with no ladder or ceiling published, and no dose is attached to either.
- The "lost 20lbs in 6 months" claim carries no study, cohort size or comparison group.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Remote Pharmacy is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Remote Pharmacy does. Both are partners: we may earn a commission if you start care through these links.
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Where this sits
#156 of 548
Ordered with the companies that pay us first, and Remote Pharmacy is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Willow
From $299/mo covering all four formats, none priced separately
- Vs median
- $124/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Willow review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.